PREDICT-DOLOR VE: Validation of a Structured Triage Protocol for Chronic Pain
Not yet recruitingNCT07696676
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
PREDICT-DOLOR VE is a structured clinical triage protocol for chronic pain that uses five internationally validated pain assessment instruments to help healthcare providers determine the appropriate level of care for patients with chronic pain. The tool operates on a free mobile-friendly platform and generates a four-level recommendation: primary care management, referral to physiatry or neurology, priority specialist evaluation, or evaluation for neurosurgical intervention. This study will validate the diagnostic accuracy of the PREDICT-DOLOR VE algorithm by comparing its recommendations with the independent assessment of a panel of three specialists in adult patients with chronic pain (lasting 3 months or longer) across three referral centers in Venezuela. The study aims to determine whether this structured, low-cost approach can help connect patients with the right type of care more quickly and consistently.
Study details
- Official title
- PREDICT-DOLOR VE: Prospective Multicenter Diagnostic Accuracy Study for the Validation of a Rule-Based Clinical Decision Support Tool for Chronic Pain Triage in a Low-Resource Setting in Venezuela
- Interventions
- Other: PREDICT-DOLOR VE
- Sponsor
- Universidad Central de Venezuela
- Start date
- 2026-08-01
- Primary completion
- 2026-12-02
- Sex
- All
- Age range
- from 18 Years to 100 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Inclusion Criteria: * Age 18 years or older * Chronic pain of any etiology with duration of 3 months or longer * Ability to complete the PREDICT-DOLOR VE digital assessment battery (with assistance if needed) * Attending one of the three participating referral centers during the recruitment period * Provision of written informed consent before any study procedure Exclusion Criteria: * Acute pain with duration less than 3 months * Active oncological pain under chemotherapy or radiotherapy protocol (separate evaluation pathway required) * Cognitive impairment that prevents completion of self-report instruments, even with assistance * Active psychiatric emergency or suicidal ideation at time of assessment * Refusal to provide informed consent * Participation in another clinical trial that could influence triage outcomes
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07696676